Event Gaps: DeepSeek's picks for 2026-10-20
DeepSeek picked NFLX, ISRG, UAL, ABT, ELV for a 1-day horizon. Intraday alpha vs SPY: -1.25%. Picks with positive alpha: 60%.
| Experiment | Event Gaps |
|---|---|
| Model | DeepSeek |
| Prompt version | event-gap-v13 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-20 |
| Measured to | 2026-10-21 |
| Benchmark | SPY |
| Status | Settled |
| Intraday alpha vs SPY | -1.25% |
| Picks with positive alpha | 60% |
| Benchmark return | -0.16% |
The picks
| Rank | Symbol | Gap direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | NFLX | -6.96% | -6.96% | 60% | -6.81% | No | |
| 2 | ISRG | -3.04% | +3.04% | 58% | +3.19% | Yes | |
| 3 | UAL | +0.56% | +0.56% | 62% | +0.72% | Yes | |
| 4 | ABT | -3.97% | -3.97% | 55% | -3.81% | No | |
| 5 | ELV | -0.31% | +0.31% | 57% | +0.47% | Yes |
The model's market view
US equities enter a heavy earnings window with megacap technology and healthcare catalysts concentrated on the evening of 20 October and the morning of 21 October 2026. Options markets price unusually large implied moves, and the one-session window captures both after-close reactions from 20 October and before-open reactions from 21 October. Directional dispersion is likely to be high, with beaten-down names offering relief-rally potential while crowded, high-expectation names carry sell-the-news risk.
Why each pick
NFLX
Prior close $69.85 on 2026-10-19; intraday indication near $69.71 at 14:47Z (delayed quote). Completed-session OHLCV could not be independently verified at answering time: daily_5d=null; return_5d_pct=null; high_20d=null; low_20d=null; avg_volume_20d=null. Price action: the stock is down roughly 20% year-to-date but has rebounded above its 20-day moving average and remains below its 60-day average; volume has been near its three-month average. Catalyst: Q3 2026 earnings are scheduled after the close on 2026-10-20, with options implying a ~9.9% move. Verified facts: consensus EPS $0.82-$0.85, revenue $12.87B, +11.8% y/y. Inference: subdued expectations and a $91.39 consensus price target (30.8% above spot) support a relief rally; counter-evidence includes ad-tier monetisation concerns and declining engagement. Invalidation: a close below the 52-week low of $65.08 would negate the rebound thesis. The post-event reaction has not yet been observed.
ISRG
Prior close $433.18 on 2026-10-19; intraday quote near $436.25 at 09:52 ET (live). Completed-session OHLCV could not be independently verified: daily_5d=null; return_5d_pct=null; high_20d=null; low_20d=null; avg_volume_20d=null. Price action: shares are up about 3.2% over the past week and sit near the upper end of their recent range; Mizuho's $415 price target is below spot, suggesting overextension. Catalyst: Q3 2026 earnings are scheduled after the close on 2026-10-20, with options implying a ~7.9% move. Verified facts: consensus EPS $2.61, revenue $2.88B, +15% y/y versus +22.9% growth in the prior-year quarter. Inference: decelerating growth and elevated expectations create downside risk if guidance is merely in line; the strongest counter-evidence is that procedure growth could beat and squeeze positioning. Invalidation: a close above $450 would signal that the market has absorbed the deceleration. The reaction has not yet been observed.
UAL
Prior close $95.60 on 2026-10-19; intraday quote near $95.79 (delayed). Completed-session OHLCV could not be independently verified: daily_5d=null; return_5d_pct=null; high_20d=null; low_20d=null; avg_volume_20d=null. Price action: the stock is down about 6.8% over the past week and trades in the lower half of its 52-week range of $84.64-$138.77; volume at 4.09M shares is slightly above its three-month average. Catalyst: Q3 2026 earnings are scheduled after the close on 2026-10-20, with options implying a ~6.1% move. Verified facts: consensus EPS $2.60, revenue $17.84B, +17.2% y/y; the analyst consensus is Strong Buy with a $152.48 target. Inference: a cheap valuation (P/E ~8.9) and resilient travel demand support upside; fuel-cost and macroeconomic concerns are the main counter-evidence. Invalidation: a close below $90 would break the recent support zone. The reaction has not yet been observed.
ABT
Prior close $104.06 on 2026-10-19; intraday quote near $104.17 (real-time). Completed-session OHLCV could not be independently verified: daily_5d=null; return_5d_pct=null; high_20d=null; low_20d=null; avg_volume_20d=null. Price action: shares are below the 50-day SMA ($105.80) but above the 200-day SMA ($102.70); RSI is 55.7 and MACD is slightly negative, indicating a consolidating trend; volume is near its three-month average. Catalyst: Q3 2026 earnings are scheduled before the open on 2026-10-21 at 07:30 ET, with options implying a ~5.7% move. Verified facts: consensus EPS $1.43-$1.45, revenue $12.91B, +13.6% y/y. Inference: the stock has de-rated from a $132.03 high, and low expectations plus dividend support could fuel a relief rally; litigation and quality overhangs are counter-evidence. Invalidation: a close below $100 would indicate that the relief-rally thesis has failed. The reaction has not yet been observed.
ELV
Prior close $430.23 on 2026-10-19; intraday quote near $436.63 at 10:36 ET (delayed). Completed-session OHLCV could not be independently verified: daily_5d=null; return_5d_pct=null; high_20d=null; low_20d=null; avg_volume_20d=null. Price action: the stock is up about 1.2% intraday but remains near the lower end of its 52-week range; revenue is expected to contract 3.9% y/y. Catalyst: Q3 2026 earnings are scheduled before the open on 2026-10-21 at 06:00 ET, with options implying a ~6.8% move. Verified facts: consensus EPS $4.66, revenue $48.71B, -3.9% y/y; Medicare Advantage cost concerns are widely reported. Inference: margin pressure and membership declines could drive a miss and extend the downtrend; a cost-control beat is the main counter-evidence. Invalidation: a close above $450 would negate the bearish thesis. The reaction has not yet been observed.
Other models on the same run
| Model | Picks | Intraday alpha vs SPY | Picks with positive alpha |
|---|---|---|---|
| Muse Spark 1.1 | GM, RTX, MMM, NFLX, SPCX | +3.52% | 60% |
| Perplexity | NFLX, TSLA, META, TXN, GM | +1.04% | 40% |
| Gemini 3 Pro | NFLX, TSLA, NVDA, MSFT, AMD | -1.62% | 40% |
| Grok 4.5 | NFLX, ISRG, TSLA, META, GM | +1.67% | 60% |
| Claude Sonnet 5.5 | COF, ISRG, NFLX, UAL, ALK | -1.00% | 40% |
| GPT-6 | NFLX, ISRG, GE, GM, RTX | +1.32% | 60% |
Written up on ForecastNest Insights: Event Gaps: DeepSeek's picks for 2026-10-20.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.